Charles A. Baker, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 15,000 shares at $171.45 ($2.6M) on 2012-11-26, disclosed to the SEC on 2012-11-27.
Scheduled sale ($2.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $171.45 | 1,100 | $189K | 7.2% |
| 2 | $172.65 | 1,200 | $207K | 7.9% |
| 3 | $173.63 | 5,035 | $874K | 33.5% |
| 4 | $174.46 | 6,565 | $1.1M | 43.9% |
| 5 | $175.14 | 1,100 | $193K | 7.4% |
| Total | $173.87 avg | 15,000 |
| $2.6M |
| 100% |
| Filing → |
| REGN | SELL | 2015-09-18 | $2.8M | — | Filing → |
| REGN | SELL | 2015-03-26 | $2.3M | — | Filing → |
| REGN | SELL | 2014-03-25 | $4.5M | — | Filing → |